Safety monitoring

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Safety Monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution.

Responsibility for data and safety monitoring depends on the phase of the study and may be conducted by sponsor or CRO staff or contractor, and/or by the Principal clinical investigator/project manager conducting the study. Regardless of the method used, monitoring must be performed on a regular basis. Oversight of the monitoring activity is the responsibility of the sponsor.

See also

• Clinical monitoring
• Data Monitoring Committee
• Serious adverse event (SAE)
• FDA
• European Medicines Agency

References

• Ariel E. Quinio, Safety in Clinical Trials: Who is Responsible?International Biopharmaceutical Association:IBPA Publications, 2005
• Carol Rados, Inside Clinical Trials Testing Medical Products in People FDA Consumer magazine, September-October 2003 Issue

External links

• ClinicalTrials.gov from US National Library of Medicine
• ICH Website
• FDA Website